Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Vifor Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Vifor Pharma AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Vifor Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Vifor Pharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Vifor Pharma AG, Medical Devices Deals, 2012 to YTD 2018 10
Vifor Pharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Vifor Pharma AG, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Relypsa Secures USD2.6 Million in Venture Funding 13
Relypsa Raises US$80 Million In Series C Financing 14
Relypsa Secures USD62.4 Million in Venture Funding 16
Partnerships 17
Helsinn Healthcare Enters into Distribution Agreement with Vifor Pharma for Aloxi 17
Relypsa Enters into Partnership with Vifor-Fresenius Medical Care Renal Pharma 18
Probi Enters Into Co-Marketing Agreement With Vifor Pharma 19
Debiopharm Enters Into Co-Marketing Agreement With Vifor Pharma For Pamorelin LA And Salvacyl 20
Licensing Agreements 21
Vifor-Fresenius Medical Care Renal Pharma Enters into Licensing Agreement with Cara Therapeutics 21
Zeria Pharma Enters into Licensing Agreement with Vifor Pharma 23
Kissei Pharma Enters into Licensing Agreement with Vifor Fresenius Medical Care Renal Pharma 24
Vifor Pharma Enters into Licensing Agreement with Akebia Therapeutics 25
Vifor Pharma Enters into Licensing Agreement with ChemoCentryx 26
Vifor Pharma Expands Licensing Agreement with ChemoCentryx for CCX168 27
Vifor Fresenius Medical Care Renal Pharma Enters into Licensing Agreement with OPKO Health for Rayaldee 28
Vifor Pharma Expands Licensing Agreement with Roche 29
Isotechnika Pharma Enters Into Licensing Agreement With Vifor Pharma For voclosporin 30
Vifor Pharma Enters into Licensing Agreement with Pfizer for Retacrit 31
Vifor Pharma Enters Into Licensing Agreement With Zeria Pharma For Ferinject 32
Helsinn Enters Into Licensing And Distribution Agreement With Vifor Pharma For Netupitant-Palonosetron 33
Equity Offering 34
Akebia Therapeutics Raises USD50 Million in Private Placement of Shares 34
Relypsa Raises USD172 Million in Public Offering of Shares 35
Relypsa Completes Public Offering Of Shares For US$101.2 Million 37
Relypsa Completes IPO For US$86.7 Million 39
Debt Offering 41
Vifor Pharma Raises USD473.6 Million in Public Offering of 0.75% Bonds Due 2022 41
Acquisition 42
Vifor Pharma to Acquire 14.6% Stake in Chemocentryx from GlaxoSmithKline 42
Galenica Acquires Relypsa for USD1.53 Billion in Tender Offer 44
Relypsa May Sell Itself 46
Vifor Pharma AG – Key Competitors 47
Vifor Pharma AG – Key Employees 48
Vifor Pharma AG – Locations And Subsidiaries 49
Head Office 49
Other Locations & Subsidiaries 49
Recent Developments 51
Financial Announcements 51
Aug 08, 2018: Vifor Pharma Group reports strong H1 2018 results, raises full-year guidance 51
Mar 15, 2018: Vifor Pharma Group Reports Strong 2017 Results, Exceeding Raised Guidance 55
Aug 08, 2017: Vifor Pharma Reports Strong H1 2017 Results And Raises Guidance 60
Corporate Communications 61
Sep 20, 2018: Vifor Pharma announces changes in management 61
Mar 29, 2018: Vifor Pharma to Propose Jacques Theurillat as Board Member 62
Government and Public Interest 63
Feb 20, 2017: Vifor Pharma and ECCO Announces One-Year Research Grant for Iron Deficiency 63
Clinical Trials 64
Feb 08, 2018: Vifor Pharma Ferroportin Inhibitor Enters Phase-I Clinical Trial 64
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65
Vifor Pharma AG, Pharmaceuticals & Healthcare, Key Facts 2
Vifor Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Vifor Pharma AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Vifor Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Vifor Pharma AG, Deals By Therapy Area, 2012 to YTD 2018 9
Vifor Pharma AG, Medical Devices Deals, 2012 to YTD 2018 10
Vifor Pharma AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Relypsa Secures USD2.6 Million in Venture Funding 13
Relypsa Raises US$80 Million In Series C Financing 14
Relypsa Secures USD62.4 Million in Venture Funding 16
Helsinn Healthcare Enters into Distribution Agreement with Vifor Pharma for Aloxi 17
Relypsa Enters into Partnership with Vifor-Fresenius Medical Care Renal Pharma 18
Probi Enters Into Co-Marketing Agreement With Vifor Pharma 19
Debiopharm Enters Into Co-Marketing Agreement With Vifor Pharma For Pamorelin LA And Salvacyl 20
Vifor-Fresenius Medical Care Renal Pharma Enters into Licensing Agreement with Cara Therapeutics 21
Zeria Pharma Enters into Licensing Agreement with Vifor Pharma 23
Kissei Pharma Enters into Licensing Agreement with Vifor Fresenius Medical Care Renal Pharma 24
Vifor Pharma Enters into Licensing Agreement with Akebia Therapeutics 25
Vifor Pharma Enters into Licensing Agreement with ChemoCentryx 26
Vifor Pharma Expands Licensing Agreement with ChemoCentryx for CCX168 27
Vifor Fresenius Medical Care Renal Pharma Enters into Licensing Agreement with OPKO Health for Rayaldee 28
Vifor Pharma Expands Licensing Agreement with Roche 29
Isotechnika Pharma Enters Into Licensing Agreement With Vifor Pharma For voclosporin 30
Vifor Pharma Enters into Licensing Agreement with Pfizer for Retacrit 31
Vifor Pharma Enters Into Licensing Agreement With Zeria Pharma For Ferinject 32
Helsinn Enters Into Licensing And Distribution Agreement With Vifor Pharma For Netupitant-Palonosetron 33
Akebia Therapeutics Raises USD50 Million in Private Placement of Shares 34
Relypsa Raises USD172 Million in Public Offering of Shares 35
Relypsa Completes Public Offering Of Shares For US$101.2 Million 37
Relypsa Completes IPO For US$86.7 Million 39
Vifor Pharma Raises USD473.6 Million in Public Offering of 0.75% Bonds Due 2022 41
Vifor Pharma to Acquire 14.6% Stake in Chemocentryx from GlaxoSmithKline 42
Galenica Acquires Relypsa for USD1.53 Billion in Tender Offer 44
Relypsa May Sell Itself 46
Vifor Pharma AG, Key Competitors 47
Vifor Pharma AG, Key Employees 48
Vifor Pharma AG, Other Locations 49
Vifor Pharma AG, Subsidiaries 49
List of Figures
Vifor Pharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vifor Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vifor Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vifor Pharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vifor Pharma AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Vifor Pharma AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Vifor Pharma AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Vifor Pharma AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Vifor Pharma AG, Medical Devices Deals, 2012 to YTD 2018 10